The journey towards safely restarting faecal microbiota transplantation services in the UK during the COVID-19 era.

Autor: Quraishi MN; University of Birmingham Microbiome Treatment Centre, Birmingham, UK.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, UK., Shabir S; University of Birmingham Microbiome Treatment Centre, Birmingham, UK., Manzoor SE; University of Birmingham Microbiome Treatment Centre, Birmingham, UK., Green CA; University of Birmingham Microbiome Treatment Centre, Birmingham, UK.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Microbiology and Infection, University of Birmingham, UK., Sharma N; University of Birmingham Microbiome Treatment Centre, Birmingham, UK.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Beggs AD; University of Birmingham Microbiome Treatment Centre, Birmingham, UK.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, UK., Iqbal TH; University of Birmingham Microbiome Treatment Centre, Birmingham, UK.; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Microbiology and Infection, University of Birmingham, UK.
Jazyk: angličtina
Zdroj: The Lancet. Microbe [Lancet Microbe] 2021 Apr; Vol. 2 (4), pp. e133-e134. Date of Electronic Publication: 2021 Feb 19.
DOI: 10.1016/S2666-5247(21)00036-7
Databáze: MEDLINE